Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations

John Hopkins professor and psychedelics expert Matthew Johnson to act as senior advisor to committee NEW YORK, March 12, 2020 /CNW/…

Mind Medicine Inc goes public on the psychedelics market

Mind Medicine Inc., a psychedelics-based medicine startup closed a $24.2 million funding before to go public…